Picton Mahoney Asset Management’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5,369	Closed	-$4K	–	1012
2025 Q1	$4K	Buy	5,369 +1,784	+50%	+$1.33K	﹤0.01%	626
2024 Q4	$6K	Buy	3,585 +1,824	+104%	+$3.05K	﹤0.01%	534
2024 Q3	$6K	Buy	+1,761	New	+$6K	﹤0.01%	520